...in a fantasy world, that is.
The first version is the "corrected" Nemeroff/Schatzberg cover, followed by the current cover. Thanks to John Nardo, who corrected the inaccurate attributions on one of his recent blog postings.
Announcement: Where to Find the New Carlat Psychiatry Blog
Earn CME Credits Online with The Carlat Psychiatry Report
Share it
Subscribe to our RSS Feed!Dr. Carlat's New Book
Click the book cover to go to the Unhinged website
About Dr. Carlat
Pharma-Skeptical Sites
Other Great Medical Blogs
Pharma-Friendly Sites
Psychiatry Links
- Child in Mind
- Clin Psych Blog
- Depression Central
- Dr Shock MD PhD
- Family Dysfunction and Mental Health Blog
- Furious Seasons Blog
- Mcman's Depression and Bipolar Web
- MI Watch
- Mind Hacks
- Neuroskeptic
- Psych Central
- Psychiatry Fun Blog
- Psychopharmacology Institute
- Shrink Rap
- The Carlat Psychiatry Report
- Thought Broadcast
CME Sites
Labels
- AARP (1)
- Abilify (6)
- ACCME (14)
- ACCME report (1)
- ACRE (3)
- ADHD (4)
- Advertising (2)
- Akathisia (2)
- Alan Schatzberg (6)
- Alison Bass (1)
- Allen Frances (2)
- Alliance for CME (2)
- Alzheimer's disease (1)
- AMA (4)
- Amen Clinics (2)
- American Academy of Allergy (1)
- American Academy of Orthopaedic Surgeons (1)
- American Board of Medical Specialties (1)
- American College of Cardiology (1)
- American Journal of Psychiatry (2)
- American Medical Association (3)
- American Psychiatric Association (8)
- American Psychiatric News (2)
- American Society of Hypertension (1)
- Anatomy of an Epidemic (1)
- Andrew Wilner (1)
- AndroGel (1)
- Angell (1)
- Antidepressants (2)
- Antidote (1)
- antipsychotics (3)
- Anxiety disorders (1)
- APA (4)
- APA election (2)
- Aplenzin (1)
- Appelbaum (1)
- Asthma and Immunology (1)
- Astra Zeneca (11)
- BBC (1)
- Behrman (1)
- Bernard Carroll (1)
- bifeprunox (2)
- Billy Rubin's Blog (1)
- BIO 2008 (1)
- Bioethics (1)
- Biomarkers (2)
- bipolar depression (1)
- bipolar disorder (1)
- Blogging (1)
- BlueSpark (1)
- BMJ (1)
- book review (1)
- Boston Globe (3)
- Boston University (1)
- Brand(x) (1)
- Bremmer (1)
- Brigham and Woman's Hospital (1)
- Bristol-Myers Squibb (8)
- British Medical Journal (3)
- BusinessWeek (3)
- CAFE study (1)
- Califf (1)
- California Academy of Family Physicians (1)
- Canadian Medical Association (1)
- Carl Elliott (1)
- Carlat CME Institute (1)
- CATIE trial (1)
- CE Measure (1)
- CECentral (1)
- CEJA (5)
- Center for Medicine in the Public Interest (1)
- Cephalon (1)
- Cervero (2)
- Chantix (1)
- Chicago Tribune (1)
- child psychiatry (1)
- Clawsen (1)
- CME (4)
- CME LLC (1)
- CME Outfitters (1)
- CME Peer Review (2)
- CME Reform (1)
- CME Rogue's Gallery (1)
- CME Zone (2)
- CNS News (1)
- CNS Spectrums (4)
- Coalition for Healthcare Communication (1)
- Colbert (1)
- commercial bias (24)
- Commercial Bias Inventory (1)
- Commercial Support Free CME (1)
- Comparative effectiveness research (1)
- Conflicts of Interest (7)
- Connors (1)
- continuing medical education (1)
- Contrave (1)
- Corruption (2)
- Council of Medical Specialty Societies (1)
- Counter-detailing (2)
- CS2day (1)
- Current Psychiatry (6)
- CVS Caremark (2)
- Cymbalta (3)
- Dallas Leipzig International Valve 2010 (1)
- data-mining (2)
- Dave Davies (1)
- David Kupfer (1)
- David Polly (1)
- Delaware Media Group (1)
- depression (1)
- Depression Central (1)
- DesignWrite (5)
- Deval Patrick (1)
- DeVane (1)
- Direct to consumer ads (1)
- dirty thirty (1)
- disclosure (1)
- Dollars for Docs (1)
- Donna Beales (1)
- Donna Norris (1)
- Doug Bremner (1)
- Dowden Health Media (2)
- Dr. Drug Rep (1)
- Dr. RW (1)
- drug companies (1)
- drug reps (3)
- Drug-drug interactions (1)
- DSM-V (6)
- DuBuske (1)
- Effexor (4)
- Eli Lilly (16)
- Emory University (6)
- EMSAM (1)
- Epocrates (1)
- Ethics Policies (1)
- Fauber (1)
- FDA (6)
- fibromyalgia (1)
- Forest Laboratories (2)
- Free samples (1)
- free speech (1)
- Fresh air (1)
- Frontline (1)
- Fugh-Berman (5)
- Functional neuroimaging (1)
- Furious Seasons (1)
- Gardiner Harris (2)
- Gawande (1)
- generics (1)
- genetics (1)
- ghostwriting (5)
- gift ban (2)
- GlaxoSmithKline (4)
- Goldberg (2)
- Goodwin (5)
- Goozner (1)
- Governor Deval Patrick (1)
- Grassley (8)
- Great Britain (1)
- Greater Boston (1)
- greed (1)
- Harvard Medical School (1)
- Haymarket Medical (1)
- Health Affairs (1)
- Health care reform (1)
- Health Care Renewal (1)
- HealthGrades (1)
- Heart Rhythm Society (1)
- hired gun (4)
- Hormone replacement therapy (1)
- i3 CME (4)
- IMS (2)
- In Her Wake (1)
- Indianapolis Star (2)
- industry-free CME (4)
- industry-funded CME (10)
- Insel (2)
- Institute for Continuing Healthcare (1)
- Institute of Medicine (1)
- Invega (2)
- iPhone (1)
- IRINE (1)
- Ivan Goldberg (1)
- JAMA (5)
- James Stein (1)
- Janssen (1)
- Jazz Pharmaceuticals (2)
- Jeffrey Flier (1)
- Jerry Avorn (1)
- John Kelsoe (1)
- John Russell (1)
- Johns Hopkins (2)
- Johnson and Johnson (1)
- Joseph Biederman (4)
- Journal of Clinical Psychiatry (4)
- Judith Graham (1)
- key opinion leaders (1)
- Kickbacks (1)
- Kulongoski (2)
- Latuda (1)
- legal consultation (1)
- Letters and Science (1)
- Lexapro (1)
- Liebowitz (1)
- Lighthouse Learning (1)
- Lisa Cosgrove (1)
- Lizbeth Kowalszyk (1)
- LLC (1)
- Lurasidone (2)
- Luvox CR (1)
- Luvox SR (1)
- M/C Communications (1)
- Macy Foundation (2)
- Manhattan Research (1)
- Marcia Angell (1)
- Marketing tactics (1)
- Martha Rosenberg (1)
- Martin Samuels (1)
- Massachusetts General Hospital (4)
- Massachusetts gift ban (11)
- McAllen (1)
- McCain (1)
- McGeeney (1)
- McMahon Publishing Group (2)
- Med Page Today (1)
- Medbribe (1)
- Medical Marketing and Media (1)
- Medical Meetings Magazine (3)
- Medical Societies (1)
- Medscape (9)
- Medtronic (2)
- Meghna Chakrabarti (1)
- Melody Peterson (1)
- Memorial Sloan-Kettering (2)
- Mental Health American (1)
- Merck (1)
- Michael First (1)
- Milwaukee Journal Sentinel (2)
- Mina Dulcan (1)
- Minh Uong (1)
- Mother Jones (1)
- Mukherjee (1)
- Nancy Rappaport (1)
- Natasha Singer (1)
- National Physician's Alliance (2)
- Nemeroff (15)
- Nesi (1)
- Neuroinvestment (1)
- Neuroscience education insttitute (1)
- neuroscienceCME (1)
- New Hampshire (2)
- New York State Assembly (1)
- New York Times (5)
- New York Times Magazine (3)
- New Yorker (1)
- Niravam (1)
- Nissen (1)
- Notes from RW (1)
- Novartis (1)
- Nuvigil (1)
- Obama (2)
- Off-label promotion (1)
- On Point (1)
- Oransky (1)
- Oregon (3)
- Oregon Academy of Family Physicians (1)
- Orexigen (1)
- Otsuka (2)
- Pain TV (1)
- Parry (1)
- Partners (2)
- Patent Extenders (1)
- Pathophilia (2)
- Patient Priming (1)
- Paul Simon (1)
- Paul Thacker (1)
- Pfizer (5)
- pharma marketing blog (1)
- Pharmaceutical marketing (2)
- Pharmed Out (2)
- PhRMA code (1)
- Physi (1)
- Physician disclosure (1)
- Physician payments (4)
- Physician Payments Sunshine Act (4)
- Pies (1)
- Placebo controlled trial (2)
- Placebo Journal Blog (1)
- podcast (1)
- Poison Pills (1)
- Policy and Medicine (2)
- practice guidelines committee (1)
- premarin (1)
- Prempro (2)
- prescription data-mining (5)
- Prescription project (1)
- prescriptive privileges (1)
- Pri-Med (1)
- Primary Psychiatry (2)
- Primedia Healthcare (1)
- Pristiq (3)
- PRMS (1)
- Product theaters (1)
- Professional Medical Associations (1)
- promotional speakers (3)
- ProPublica (4)
- Psychiatric Times (3)
- psychologists (3)
- psychosis (1)
- psychotherapy (2)
- Psynomics (1)
- PV Updates (1)
- QuantiaMD (1)
- Radio Boston (1)
- Reed Elsevier (1)
- Relman (1)
- Remission (1)
- Reporting on Health (1)
- Ridge Diagnostics (1)
- Robert DeLeo (1)
- Robert Freedman (1)
- Royal College of Physicians (1)
- Rozerem (1)
- sanofi aventis (1)
- SAPHRIS (2)
- Schatzberg (2)
- Schering-Plough (2)
- Schwarz Pharma (1)
- Schwitzer (1)
- seeding trials (1)
- Senate Aging Committee (2)
- Senate Finance Committee (1)
- Senator Herb Kohl (2)
- SentinelSource (1)
- Sepracor (1)
- Seroquel (11)
- Shahram Ahari (1)
- Sharfstein (1)
- Shire (4)
- Silenor (1)
- SmithKline Beecham (1)
- Soltan (2)
- Solvay (3)
- Somaxon (1)
- SPECT (1)
- Spencer (1)
- Spielmans (1)
- Stanford University (2)
- Stephen Stahl (3)
- Sternthal (1)
- Steve DiFillippo (2)
- Steven Stahl (1)
- Stossel (1)
- Stowe (2)
- Strattera (1)
- Sunovion (2)
- super PACs (1)
- surveys (2)
- Symbyax (1)
- Takeda (1)
- Tamar Hosansky (1)
- testosterone (1)
- Thacker (1)
- The Carlat Medical Report (1)
- The Infinite Mind (4)
- The Psychiatrist's Program (2)
- Thomas Sullivan (1)
- Thought Broadcast (1)
- Tim Kuklo (1)
- Tom Ashbrook (1)
- Tom Sullivan (1)
- Tufts (1)
- Unbranded Doctor (1)
- University Diaries (1)
- University of Michigan (1)
- University of North Texas Health Science Center (1)
- University of Wisconsin (3)
- Verispan (1)
- Vermont (2)
- Vermont Psychiatric Association (1)
- Viibryd (1)
- vilazodone (1)
- Vioxx (1)
- Viracept (1)
- Vox Medica (1)
- Vyvanse (1)
- Wall Street Journal Health Blog (1)
- Washington Post (1)
- WebMD (1)
- Whitaker (1)
- Wilens (1)
- William Carpenter (1)
- William Heisel (2)
- Wired magazine (1)
- Wisconsin Medical Society (1)
- Wood (1)
- Wyeth Pharmaceuticals (12)
- Zimmerman (1)
- Zyprexa (2)
4 comments:
Damn. For a second there I thought it really happened! Talk about wishful thinking.
I believed you...
I actually believed you.
Guess that's FAIL for me on the mini mental today.
This would have been a great April Fool's Day joke!
Ah but if it were really honest it would have to be retitled as well.
"Recognition and Treatment of People Who Might Buy Our Drugs: A Marketing Pamphlet"?
Post a Comment